Inactive Instrument

Natco Pharma Ltd. Stock NSE India S.E.

Equities

INE987B01018

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Natco Pharma Ltd.
Sales 2024 * 39.19B 470M Sales 2025 * 45.13B 542M Capitalization 185B 2.22B
Net income 2024 * 13.21B 159M Net income 2025 * 15.27B 183M EV / Sales 2024 * 4.33 x
Net cash position 2024 * 15.67B 188M Net cash position 2025 * 31.57B 379M EV / Sales 2025 * 3.4 x
P/E ratio 2024 *
14.1 x
P/E ratio 2025 *
12.3 x
Employees -
Yield 2024 *
0.97%
Yield 2025 *
1.09%
Free-Float 46.76%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 46 00-07-02
Founder 78 81-09-18
Director of Finance/CFO - -
Members of the board TitleAgeSince
Founder 78 81-09-18
Chief Executive Officer 46 00-07-02
Director/Board Member 70 14-04-17
More insiders
Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with focus on research and development. The Company is engaged in in the development, manufacturing and commercialization of complex pharmaceuticals that target specific therapeutic areas. It specializes in catering to niche markets and offering solutions to address complex medical needs. It owns nine manufacturing facilities across India and two research centers in Telangana. The Company’s segment includes Pharmaceuticals and Agro chemicals. Its Pharmaceuticals segment is engaged in manufacturing and selling of bulk drugs, finished dosage formulations and related services. Its Agro Chemicals is engaged in manufacturing and selling of agro chemical. It manufactures active pharmaceutical ingredients products which are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe, and United States of America.
More about the company